MicroRNA-21, -126 and -146a as potential novel systemic markers of metabolic syndrome

Obesity and overweight have reached epidemic proportions. These conditions increase the risk of numerous health problem, including metabolic syndrome (MetS). Hormonal changes during menopause transition may be related to the increased frequency of the MetS. Circulating microRNAs (miRNAs) are easily...

Full description

Bibliographic Details
Main Author: Tuominen, Jenni
Other Authors: Matemaattis-luonnontieteellinen tiedekunta, Faculty of Sciences, Bio- ja ympäristötieteiden laitos, Department of Biological and Environmental Science, Jyväskylän yliopisto, University of Jyväskylä
Format: Master's thesis
Language:eng
Published: 2018
Subjects:
Online Access: https://jyx.jyu.fi/handle/123456789/60160
_version_ 1826225745092935680
author Tuominen, Jenni
author2 Matemaattis-luonnontieteellinen tiedekunta Faculty of Sciences Bio- ja ympäristötieteiden laitos Department of Biological and Environmental Science Jyväskylän yliopisto University of Jyväskylä
author_facet Tuominen, Jenni Matemaattis-luonnontieteellinen tiedekunta Faculty of Sciences Bio- ja ympäristötieteiden laitos Department of Biological and Environmental Science Jyväskylän yliopisto University of Jyväskylä Tuominen, Jenni Matemaattis-luonnontieteellinen tiedekunta Faculty of Sciences Bio- ja ympäristötieteiden laitos Department of Biological and Environmental Science Jyväskylän yliopisto University of Jyväskylä
author_sort Tuominen, Jenni
datasource_str_mv jyx
description Obesity and overweight have reached epidemic proportions. These conditions increase the risk of numerous health problem, including metabolic syndrome (MetS). Hormonal changes during menopause transition may be related to the increased frequency of the MetS. Circulating microRNAs (miRNAs) are easily detectable in blood and have a potential to act as non-invasive biomarkers. MiR-21, miR-126, and miR-146a were selected in this Master’s thesis because they are associated with MetS risk factors and menopause-related hormone estradiol (E2). Hypothesis of this study was that circulating miR-21, miR-126 and miR-146a levels may vary in different MetS risk factor groups and stage of menopause. Participants (n=137) were divided to the MetS risk factor groups; healthy (n=35), risk 1 (n=35), risk 2 (n=33), and MetS (n=34), based on anthropometrics and measured blood characteristics. Menopause groups; pre- (n=45), peri- (n=44) and postmenopause (n=48) were divided based on blood test and menstrual diary. Circulating miRNAs levels were quantified with quantitative polymerase chain reaction (qPCR). The results could not establish distinct association between serum miR-21, miR-126 and miR-146a to the risk factor groups of MetS or to the stage of menopause. However, significant correlation was observed between miR-21 and E2, miR-21 and glucose and miR-126 and glucose. Based on the results of this thesis, despite the associations found between miRNAs and glucose, the studied miRNAs cannot be considered as markers of MetS.
first_indexed 2019-08-19T08:21:09Z
format Pro gradu
free_online_boolean 1
fullrecord [{"key": "dc.contributor.advisor", "value": "Laakkonen, Eija", "language": "", "element": "contributor", "qualifier": "advisor", "schema": "dc"}, {"key": "dc.contributor.author", "value": "Tuominen, Jenni", "language": "", "element": "contributor", "qualifier": "author", "schema": "dc"}, {"key": "dc.date.accessioned", "value": "2018-11-08T06:44:04Z", "language": null, "element": "date", "qualifier": "accessioned", "schema": "dc"}, {"key": "dc.date.available", "value": "2018-11-08T06:44:04Z", "language": null, "element": "date", "qualifier": "available", "schema": "dc"}, {"key": "dc.date.issued", "value": "2018", "language": "", "element": "date", "qualifier": "issued", "schema": "dc"}, {"key": "dc.identifier.uri", "value": "https://jyx.jyu.fi/handle/123456789/60160", "language": null, "element": "identifier", "qualifier": "uri", "schema": "dc"}, {"key": "dc.description.abstract", "value": "Obesity and overweight have reached epidemic proportions. These conditions increase the risk of numerous health problem, including metabolic syndrome (MetS). Hormonal changes during menopause transition may be related to the increased frequency of the MetS. Circulating microRNAs (miRNAs) are easily detectable in blood and have a potential to act as non-invasive biomarkers. MiR-21, miR-126, and miR-146a were selected in this Master\u2019s thesis because they are associated with MetS risk factors and menopause-related hormone estradiol (E2). Hypothesis of this study was that circulating miR-21, miR-126 and miR-146a levels may vary in different MetS risk factor groups and stage of menopause. Participants (n=137) were divided to the MetS risk factor groups; healthy (n=35), risk 1 (n=35), risk 2 (n=33), and MetS (n=34), based on anthropometrics and measured blood characteristics. Menopause groups; pre- (n=45), peri- (n=44) and postmenopause (n=48) were divided based on blood test and menstrual diary. Circulating miRNAs levels were quantified with quantitative polymerase chain reaction (qPCR). The results could not establish distinct association between serum miR-21, miR-126 and miR-146a to the risk factor groups of MetS or to the stage of menopause. However, significant correlation was observed between miR-21 and E2, miR-21 and glucose and miR-126 and glucose. Based on the results of this thesis, despite the associations found between miRNAs and glucose, the studied miRNAs cannot be considered as markers of MetS.", "language": "en", "element": "description", "qualifier": "abstract", "schema": "dc"}, {"key": "dc.description.provenance", "value": "Submitted by Paivi Vuorio (paelvuor@jyu.fi) on 2018-11-08T06:44:04Z\nNo. of bitstreams: 0", "language": "en", "element": "description", "qualifier": "provenance", "schema": "dc"}, {"key": "dc.description.provenance", "value": "Made available in DSpace on 2018-11-08T06:44:04Z (GMT). No. of bitstreams: 0\n Previous issue date: 2018", "language": "en", "element": "description", "qualifier": "provenance", "schema": "dc"}, {"key": "dc.format.extent", "value": "37", "language": "", "element": "format", "qualifier": "extent", "schema": "dc"}, {"key": "dc.format.mimetype", "value": "application/pdf", "language": null, "element": "format", "qualifier": "mimetype", "schema": "dc"}, {"key": "dc.language.iso", "value": "eng", "language": null, "element": "language", "qualifier": "iso", "schema": "dc"}, {"key": "dc.rights", "value": "In Copyright", "language": "en", "element": "rights", "qualifier": null, "schema": "dc"}, {"key": "dc.subject.other", "value": "circulating microRNAs", "language": "", "element": "subject", "qualifier": "other", "schema": "dc"}, {"key": "dc.subject.other", "value": "biomarker", "language": "", "element": "subject", "qualifier": "other", "schema": "dc"}, {"key": "dc.title", "value": "MicroRNA-21, -126 and -146a as potential novel systemic markers of metabolic syndrome", "language": "", "element": "title", "qualifier": null, "schema": "dc"}, {"key": "dc.type", "value": "master thesis", "language": null, "element": "type", "qualifier": null, "schema": "dc"}, {"key": "dc.identifier.urn", "value": "URN:NBN:fi:jyu-201811084651", "language": "", "element": "identifier", "qualifier": "urn", "schema": "dc"}, {"key": "dc.type.ontasot", "value": "Pro gradu -tutkielma", "language": "fi", "element": "type", "qualifier": "ontasot", "schema": "dc"}, {"key": "dc.type.ontasot", "value": "Master\u2019s thesis", "language": "en", "element": "type", "qualifier": "ontasot", "schema": "dc"}, {"key": "dc.contributor.faculty", "value": "Matemaattis-luonnontieteellinen tiedekunta", "language": "fi", "element": "contributor", "qualifier": "faculty", "schema": "dc"}, {"key": "dc.contributor.faculty", "value": "Faculty of Sciences", "language": "en", "element": "contributor", "qualifier": "faculty", "schema": "dc"}, {"key": "dc.contributor.department", "value": "Bio- ja ymp\u00e4rist\u00f6tieteiden laitos", "language": "fi", "element": "contributor", "qualifier": "department", "schema": "dc"}, {"key": "dc.contributor.department", "value": "Department of Biological and Environmental Science", "language": "en", "element": "contributor", "qualifier": "department", "schema": "dc"}, {"key": "dc.contributor.organization", "value": "Jyv\u00e4skyl\u00e4n yliopisto", "language": "fi", "element": "contributor", "qualifier": "organization", "schema": "dc"}, {"key": "dc.contributor.organization", "value": "University of Jyv\u00e4skyl\u00e4", "language": "en", "element": "contributor", "qualifier": "organization", "schema": "dc"}, {"key": "dc.subject.discipline", "value": "Solu- ja molekyylibiologia", "language": "fi", "element": "subject", "qualifier": "discipline", "schema": "dc"}, {"key": "dc.subject.discipline", "value": "Cell and molecular biology", "language": "en", "element": "subject", "qualifier": "discipline", "schema": "dc"}, {"key": "yvv.contractresearch.funding", "value": "0", "language": "", "element": "contractresearch", "qualifier": "funding", "schema": "yvv"}, {"key": "dc.type.coar", "value": "http://purl.org/coar/resource_type/c_bdcc", "language": null, "element": "type", "qualifier": "coar", "schema": "dc"}, {"key": "dc.rights.accesslevel", "value": "openAccess", "language": null, "element": "rights", "qualifier": "accesslevel", "schema": "dc"}, {"key": "dc.type.publication", "value": "masterThesis", "language": null, "element": "type", "qualifier": "publication", "schema": "dc"}, {"key": "dc.subject.oppiainekoodi", "value": "4013", "language": "", "element": "subject", "qualifier": "oppiainekoodi", "schema": "dc"}, {"key": "dc.subject.yso", "value": "metabolinen oireyhtym\u00e4", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "vaihdevuodet", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "mikro-RNA", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "metabolic syndrome", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "menopause", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.subject.yso", "value": "microRNA", "language": null, "element": "subject", "qualifier": "yso", "schema": "dc"}, {"key": "dc.format.content", "value": "fulltext", "language": null, "element": "format", "qualifier": "content", "schema": "dc"}, {"key": "dc.rights.url", "value": "https://rightsstatements.org/page/InC/1.0/", "language": null, "element": "rights", "qualifier": "url", "schema": "dc"}, {"key": "dc.type.okm", "value": "G2", "language": null, "element": "type", "qualifier": "okm", "schema": "dc"}]
id jyx.123456789_60160
language eng
last_indexed 2025-02-18T10:54:15Z
main_date 2018-01-01T00:00:00Z
main_date_str 2018
online_boolean 1
online_urls_str_mv {"url":"https:\/\/jyx.jyu.fi\/bitstreams\/8bd0b5b9-ecff-4311-9571-e7c1a195bdea\/download","text":"URN:NBN:fi:jyu-201811084651.pdf","source":"jyx","mediaType":"application\/pdf"}
publishDate 2018
record_format qdc
source_str_mv jyx
spellingShingle Tuominen, Jenni MicroRNA-21, -126 and -146a as potential novel systemic markers of metabolic syndrome circulating microRNAs biomarker Solu- ja molekyylibiologia Cell and molecular biology 4013 metabolinen oireyhtymä vaihdevuodet mikro-RNA metabolic syndrome menopause microRNA
title MicroRNA-21, -126 and -146a as potential novel systemic markers of metabolic syndrome
title_full MicroRNA-21, -126 and -146a as potential novel systemic markers of metabolic syndrome
title_fullStr MicroRNA-21, -126 and -146a as potential novel systemic markers of metabolic syndrome MicroRNA-21, -126 and -146a as potential novel systemic markers of metabolic syndrome
title_full_unstemmed MicroRNA-21, -126 and -146a as potential novel systemic markers of metabolic syndrome MicroRNA-21, -126 and -146a as potential novel systemic markers of metabolic syndrome
title_short MicroRNA-21, -126 and -146a as potential novel systemic markers of metabolic syndrome
title_sort microrna 21 126 and 146a as potential novel systemic markers of metabolic syndrome
title_txtP MicroRNA-21, -126 and -146a as potential novel systemic markers of metabolic syndrome
topic circulating microRNAs biomarker Solu- ja molekyylibiologia Cell and molecular biology 4013 metabolinen oireyhtymä vaihdevuodet mikro-RNA metabolic syndrome menopause microRNA
topic_facet 4013 Cell and molecular biology Solu- ja molekyylibiologia biomarker circulating microRNAs menopause metabolic syndrome metabolinen oireyhtymä microRNA mikro-RNA vaihdevuodet
url https://jyx.jyu.fi/handle/123456789/60160 http://www.urn.fi/URN:NBN:fi:jyu-201811084651
work_keys_str_mv AT tuominenjenni microrna21126and146aaspotentialnovelsystemicmarkersofmetabolicsyndrome